Last night Tissuemed beat off the field to scoop Medilink’s Outstanding Achievement Award in recognition of the company’s fabulous accomplishment in gaining Chinese regulatory approval. More to follow as the news sinks in, but for now here’s Medilink Yorkshire and Humber’s announcement:
Outstanding Achievement Award
Winner: Tissuemed Ltd.
In May 2016 Tissuemed received regulatory approval from the Chinese FDA for its TissuePatch range of surgical sealant films. With fewer than 20 employees, the company achieved the registration ahead of multibillion-dollar global corporations. The awards judges said that Tissuemed had shown true tenacity and potentially opened up a huge market.
Also shortlisted for the Outstanding Achievement award were Mednet; Aseptic Unit, B.Braun Medical Ltd.
For Tissuemed, CEO David Mandley stated “We gained huge satisfaction and an immediate boost for our business when we were granted Chinese FDA approval last year. This is the icing on the cake and it’s wonderful to be recognised by our peers in the close-knit medtech community. This award is the culmination of many years hard work for Tissuemed and I’m absolutely thrilled for the team and our family of stakeholders.”